Preparation of Co-Amorphous Levofloxacin Systems for Pulmonary Application

• Päätekijät: Aljoscha Gabelmann (Tekijä), Claus-Michael Lehr (Tekijä), Holger Grohganz (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2023-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Addressing antimicrobial resistance requires new approaches in various disciplines of pharmaceutical sciences. The fluoroquinolone levofloxacin (LEV) plays an important role in the therapy of lung infections. However, its effectiveness is limited by its severe side effects involving tendinopathy, mu...